Tomas Kiselak

Tomas is currently managing member at Fairmount Funds Management LLC, a healthcare investment fund he co-founded in April 2016. Prior to Fairmount, Mr. Kiselak served as a managing director at RA Capital Management LLC, based in Boston. Tomas also serves on the board of directors of Zenas BioPharma (ZBIO), Viridian Therapeutics (VRDN), Spyre Therapeutics (SYRE), and Apogee Therapeutics (APGE). He received his BA in Neuroscience and Economics from Amherst College.